The Center for Cholesterol Management - a medical corporation
Lipid Education
Press & Media
About Us
Beating Heart Disease

Lipid Education Home



Heart Disease 

Case Study 

Frequently Asked Questions 

Glossary of Terms 

Resources for Health Care Professionals

Resources for Patients 

Lipid Education


This Educational Resources section is a joint effort between Dr Michael Richman, MD, FACS, FCCP and Dr Thomas Dayspring, MD, FACP to provide the most accurate and up-to-date lipid information to both patients and healthcare professionals. Here you'll find papers, presentations, videos and various other resources.

The resources presented here are divided into sections for easy access by both patients and healthcare professionals.

About the Author

Dr Michael Richman

Dr Michael F Richman, MD, FACS, FCCP
Director: The Center for Cholesterol Management and The Elite Laser Vein Center

Dr. Richman is a diplomate in the American Board of Surgery and the American Board of Thoracic Surgery, a fellow in the American College of Surgeons and a fellow in the American College of Chest Physicians. In 2002-2003, he was listed by the Consumers' Research Council of America in the "Guide to America's Top Surgeons."

Curriculum Vitae

After completing both his undergraduate and medical degree at Georgetown University, Dr. Richman received a coveted general surgery residency at the University of Southern California (USC) School of Medicine. Wanting to further his surgical career, he was invited to do a fellowship in cardiothoracic and vascular surgery at Jackson Memorial Hospital at the University of Miami. He is board-certified in general surgery by the American Board of Surgery and also board-certified in cardiothoracic surgery by the American Board of Thoracic Surgery. He is also a fellow in both The American College of Surgeons and the American College of Chest Physicians. While he was born in Illinois, Dr. Richman lived most of his childhood in Beverly Hills, California, graduating from Beverly Hills High School.

Having performed over one thousand cardiac bypass procedures throughout his career, Dr. Richman has always maintained a strong interest in the preventative aspect of cardiac care, namely cholesterol (lipid) management. Currently, Dr. Richman was the cholesterol expert on WebMD from 2005-2012 and is currently on WebMD's Medical Review Board. He is also the national heart health examiner for The, and the medical expert to the nationally syndicated "The Dennis Prager Show". He also is a published author in the field of Lipidology, and is on the editorial board of peer-reviewed journal, The Journal of Clinical Lipidology, which is the official journal of The National Lipid Association. As a long-standing member of the National Lipid Association, Dr. Richman started The Center for Cholesterol Management in August 2005 in order to focus exclusively on preventative care and management for those who may be at risk for cardiovascular disease and maintains a very busy clinical practice.

The Center for Cholesterol Management is the only free-standing facility in Southern California to deliver state-of-the-art diagnosis and treatment of lipid disorders using advanced lipoprotein and comprehensive cardiovascular testing that quantitates the number of atherogenic lipoprotein particles to better identify and manage patients at risk for coronary heart disease. Dr. Richman is one of very few heart surgeons with a practice dedicated to advanced lipoprotein testing and the prevention of heart disease. More information can be found at

In late 2006, Dr. Richman opened the Elite Laser Vein Center in order to treat and provide the newest cutting edge procedures to tackle the often misunderstood problem of venous disease. He is one of the few surgeons in the Los Angeles Area that performs endovenous laser ablations and has performed more than 500 of these procedures. His clinic also serves patients in need of wound care and venous ulcers and is the principal investigator in an IRB approved clinical trial looking at the role of the MTHFR gene polymorphism contributes to venous disease and superficial thrombophlebitis.